This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guo, S. S. Articles by Sawicki, M. P. Search for Related Content PubMed PubMed Citation Articles by Guo, S. S. Articles by Sawicki, M. P.

Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1

Department of Surgery, West Los Angeles Veterans Affairs Medical Center and the University of California Los Angeles School of Medicine, Los Angeles, California 90073

ABSTRACT

Multiple endocrine neoplasia type 1 (MEN1) is a rare but informative syndrome for endocrine tumorigenesis. Since its isolation, several groups have begun to determine the role of menin, the protein product of MEN1, in sporadic endocrine tumors as well as tumors of the MEN1 syndrome. Mutations of menin have been reported in more than 400 families and tumors, most of which are truncating mutations, thus supporting the function of menin as a tumor suppressor. The exact function of menin is unknown, but overexpression of menin inhibits proliferation of Ras-transformed NIH3T3 cells. Since menin interacts with proteins from both the TGFß and AP-1 signaling pathways, perhaps its tumor suppressor function is related to these key cell growth pathways. In this review we will discuss the various clinical manifestations of MEN1 syndrome, potential mechanisms of MEN1 tumorigenesis, and mutations associated with MEN and sporadic endocrine tumors.

This article has been cited by other articles:

				A. Matoso, Z. Zhou, R. Hayama, A. Flesken-Nikitin, and A. Yu. Nikitin Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia Carcinogenesis, March 1, 2008; 29(3): 620 - 628. [Abstract] [Full Text] [PDF]

				O Vierimaa, T M L Ebeling, S Kytola, R Bloigu, E Eloranta, J Salmi, E Korpi-Hyovalti, L Niskanen, A Orvola, E Elovaara, et al. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation Eur. J. Endocrinol., September 1, 2007; 157(3): 285 - 294. [Abstract] [Full Text] [PDF]

				H. Yaguchi, N. Ohkura, M. Takahashi, Y. Nagamura, I. Kitabayashi, and T. Tsukada Menin Missense Mutants Associated with Multiple Endocrine Neoplasia Type 1 Are Rapidly Degraded via the Ubiquitin-Proteasome Pathway Mol. Cell. Biol., August 1, 2004; 24(15): 6569 - 6580. [Abstract] [Full Text] [PDF]

				T. Ebeling, O. Vierimaa, S. Kytola, J. Leisti, and P. I. Salmela Effect of Multiple Endocrine Neoplasia Type 1 (MEN1) Gene Mutations on Premature Mortality in Familial MEN1 Syndrome with Founder Mutations J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3392 - 3396. [Abstract] [Full Text] [PDF]

				A. Lacerte, E.-H. Lee, R. Reynaud, L. Canaff, C. de Guise, D. Devost, S. Ali, G. N. Hendy, and J.-J. Lebrun Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin Mol. Endocrinol., June 1, 2004; 18(6): 1558 - 1569. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, L. Canaff, G. N. Hendy, T. Tsukamoto, T. Yamaguchi, K. Miyazono, T. Sugimoto, and K. Chihara Inactivation of Menin, the Product of the Multiple Endocrine Neoplasia Type 1 Gene, Inhibits the Commitment of Multipotential Mesenchymal Stem Cells into the Osteoblast Lineage J. Biol. Chem., May 30, 2003; 278(23): 21058 - 21069. [Abstract] [Full Text] [PDF]

				C. A. Koch, K. Pacak, and G. P. Chrousos The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5367 - 5384. [Abstract] [Full Text] [PDF]

				H. Yaguchi, N. Ohkura, T. Tsukada, and K. Yamaguchi Menin, the Multiple Endocrine Neoplasia Type 1 Gene Product, Exhibits GTP-hydrolyzing Activity in the Presence of the Tumor Metastasis Suppressor nm23 J. Biol. Chem., October 4, 2002; 277(41): 38197 - 38204. [Abstract] [Full Text] [PDF]

				M. A. Kouvaraki, J. E. Lee, S. E. Shapiro, R. F. Gagel, S. I. Sherman, R. V. Sellin, G. J. Cote, and D. B. Evans Genotype-Phenotype Analysis in Multiple Endocrine Neoplasia Type 1 Arch Surg, June 1, 2002; 137(6): 641 - 647. [Abstract] [Full Text] [PDF]